Pure Global
NCT05871957

Adjuvant Therapeutic Effect of Vitamin D on Hashimoto's Thyroiditis

Qianfoshan Hospital·ClinicalTrials.gov·drugNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Hashimoto Thyroiditis
Drug/Device/Intervention
Vitamin D Drops
Study type
Observational
Intervention type
drug
Sponsor & location
Primary sponsor
Qianfoshan Hospital
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2023
End date
Sep 30, 2023
Enrollment
30 participants
Primary outcome

TPOAB in IU/ml

Summary

The purpose of this study is to explore the relationship between vitamin D and Hashimoto's
 thyroiditis and to explore whether vitamin D can play an adjuvant role in the treatment of
 Hashimoto's thyroiditis. Epidemiological surveys show that vitamin D deficiency rates are as
 high as 50%-90% in HT patients. Dietary supplementation with vitamin D has been evaluated as
 a way to protect the thyroid gland from autoimmune damage, but the results of randomized
 clinical trials are unclear.

ICD-10 classifications
ThyroiditisThyroiditis, unspecifiedDisorders of thyroid glandDisorder of thyroid, unspecifiedOther disorders of thyroid
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05871957
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05871957 through Pure Global AI's free database. This phase not specified trial is sponsored by Qianfoshan Hospital and is currently Not yet recruiting. The study focuses on Hashimoto Thyroiditis. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.